MBTPS1 and Salmonella Infections: The elucidation of the role of S1P signaling in immune responses in mammals led to the development of immunosuppressive agents such as Fingolimod (FTY720) [27] as well as highlighting potential novel therapies for intestinal Salmonella infections [28].